ExodusPoint Capital Management, LP - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$43,000
-71.7%
10,479
-75.0%
0.00%
-50.0%
Q3 2021$152,000
-25.5%
41,888
-10.6%
0.00%0.0%
Q2 2021$204,000
-82.9%
46,843
-83.9%
0.00%
-88.2%
Q1 2021$1,196,000
+408.9%
291,076
+240.7%
0.02%
+183.3%
Q2 2020$235,000
-58.6%
85,430
-29.1%
0.01%
-45.5%
Q4 2019$567,000120,5660.01%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders